# iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications

> **NCT03478293** · NA · TERMINATED · sponsor: **Glaukos Corporation** · enrollment: 6 (actual)

## Conditions studied

- Primary Open Angle Glaucoma (POAG)

## Interventions

- **DEVICE:** iStent inject surgery

## Key facts

- **NCT ID:** NCT03478293
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-02-27
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Business Decision
- **Last updated:** 2022-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03478293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03478293, "iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03478293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*